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Purpose: To evaluate the efficacy and safety of combined viscocanalostomy and 
phacoemulsiﬁ  cation (phacoviscocanalostomy) for medically uncontrolled open-angle glaucoma 
(OAG) with concomitant age-related cataract.
Design: Prospective, noncomparative, interventional case-series study.
Methods: Phacoviscocanalostomy was performed on 50 eyes of 50 consecutive patients with 
medically uncontrolled OAG and clinically signiﬁ  cant age-related cataract. Surgical outcome 
was deﬁ  ned as an overall success by the following criteria: no visual ﬁ  eld deterioration; no 
optic-neuropathy progression; postoperative intraocular pressure (IOP)  20 mmHg and IOP 
reduction  30% compared to baseline values with or without medication. When medications 
were not required, success was deﬁ  ned as complete. The surgical outcome and the complication 
rates were documented and analyzed up to 36 months postoperatively.
Results: Mean follow-up (±SD) was 29.02 ± 7.09 months. Mean, baseline IOP (±SD) had 
signiﬁ  cantly decreased from 23.51 ± 4.48 mmHg to 14.06 ± 1.64 mmHg at the last follow-up 
visit for each patient (p  0.001). The overall success was 94% at 12 months, 92% at 24 months, 
and 82% at 36 months. The success was complete in 74% at 12 months, and in 67% at 24 months 
and at 36 months. No serious complications were documented.
Conclusion: Phacoviscocanalostomy can be considered an efﬁ  cient and safe alternative surgical 
modality for medically uncontrolled OAG with concomitant age-related cataract.
Keywords: age-related cataract, non-penetrating glaucoma surgery, open-angle glaucoma, 
phacoemulsiﬁ  cation, phacoviscocanalostomy, viscocanalostomy
Introduction
The prevalence of both cataract and glaucoma increases with age. Thus, with an 
ageing population, a large proportion of observed blindness is necessarily related 
to these two pathologies (Kocur and Resnikoff 2002). The increased risk of cataract 
development in some glaucoma patients (Heijl et al 2002; Kass et al 2002), the 
signiﬁ  cantly increased risk of cataract development after glaucoma surgery (Hylton 
et al 2003), and the need to minimize both trauma and cost induced by two separate 
surgical procedures, has made combined cataract and glaucoma surgery an appealing 
therapeutic approach (Casson and Salmon 2001; Vass and Menapace 2004; Verges 
et al 2005). Indeed, combined phacoemulsiﬁ  cation with trabeculectomy (phacotra-
beculectomy) has become a popular treatment for glaucomatous eyes with visually 
signiﬁ  cant cataract (Lemon et al 1998; Shingleton et al 1999; Vyas et al 1999; Li 
et al 2000). However, both trabeculectomy and phacotrabeculectomy are associ-
ated with potentially serious complications (Bellucci et al 1997; Sihota et al 1998; 
DeBry et al 2002; Edmunds et al 2002) such as bleb leaks, hypotony, ﬂ  at anterior 
chamber, choroidal detachment, and endophthalmitis. In order to avoid these com-
plications, alternative surgical modalities have before emerged. Viscocanalostomy, 
a relatively new, non-penetrating ﬁ  ltering surgical procedure, has been reported to 
efﬁ  ciently and safely reduce intraocular pressure (IOP) in various types of open-angle Clinical Ophthalmology 2007:1(4) 498
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glaucoma (OAG) (Stegmann et al 1999; Drusedau et al 
2000; Sunaric-Megevand and Leuenberger 2001; Carassa 
et al 2002; Miserocchi et al 2004; Stangos et al 2005). When 
combined with phacoemulsiﬁ  cation surgery, viscocanalos-
tomy (phacoviscocanalostomy) has similarly been reported 
to efﬁ  ciently and safely reduce IOP while improving visual 
acuity (Gimbel et al 1999; Wishart et al 2002; Park et al 
2004, 2006; Wishart and Dagres 2006), yet more data are 
necessary. We conducted a study on phacoviscocanalos-
tomy for uncontrolled OAG with concomitant age-related 
cataract, and we herein present our results.
Patients and methods
This was a prospective, non-comparative study of 50 eyes of 
50 consecutive patients with medically uncontrolled OAG 
and age-related cataract, on whom phacoviscocanalostomy 
was performed. The same, experienced phacoemulsiﬁ  cation 
and viscocanalostomy surgeon (GSM) operated on all of 
the cases using the same standardized surgical technique 
between September 2002 and July 2004. Surgery and post-
operative follow-up were offered either in the University 
Eye Clinic or in the Clinique Générale Beaulieu, Fondation 
Rothschild in Geneva, Switzerland. We included cases of 
medically uncontrolled OAG with concomitant clinically 
signiﬁ  cant age-related cataract. Cases with dysgenetic, 
uveitic, traumatic, neovascular or angle-closure glaucoma, 
as well as cases with cataract other than age-related or 
cases with a known life-threatening disease, were excluded 
from the study. Preoperative baseline evaluation included: 
best-corrected visual acuity (BCVA); IOP measurement 
(under maximal tolerated medication, and without diurnal 
ﬂ  uctuation taken into account); slit-lamp biomicroscopy; 
gonioscopy; ultrasound corneal pachymetry; indirect fun-
doscopy with recording of the optic disc size, the vertical 
and horizontal cup/disc ratio, the presence of rim notch-
ing or splinter hemorrhages and the morphology of the 
peripapillary area; optic-disc stereoscopic photography; 
automated perimetry (Octopus 101, Interzeag, Switzer-
land); medication and family history documentation. The 
study protocol and consent forms were approved by the 
Institutional Review Boards of both participating institu-
tions. Patients were informed on the purpose of the study 
and they provided written informed consents.
Surgical procedure and postoperative 
care
In all cases, anesthesia was peribulbar (Lidocaine-Adrenalin). 
Viscocanalostomy was the ﬁ  rst step of the combined procedure, 
and it was based on the original description by Stegmann 
and coworkers (Stegmann et al 1999). The conjunctival 
ﬂ  ap was fornix-based. To avoid damage to Schlemm’s 
canal (SC), to the collector channels and to the episcleral 
vascular bed, diathermy was not used. Instead, hemosta-
sis was achieved by terlipressin-embedded (Glypressine, 
Ferring AG, Malmö, Sweden) sponge application on the 
surgical wound. A site with at least one apparent collecting 
channel was chosen and a 5 × 5 mm limbal-based rectangular 
or parabolic, thin superﬁ  cial scleral ﬂ  ap was dissected 1.5 mm 
into clear cornea. By using a specially designed scleral 
knife (Scleral Pocket Knife 681.26, Grieshaber and Co. 
AG, Schaffhausen, Switzerland), a second, deep scleral ﬂ  ap 
was dissected close to the ciliary body. When reaching SC, 
the latter was unroofed by gently pulling on the scleral ﬂ  ap 
and concomitantly peeling the ﬁ  brotic lining from the bottom 
of the canal by means of a triangular cellulose sponge. This 
same procedure was continued into a cleavage plane, between 
the corneal stroma and the Descemet’s membrane, creating 
a trabeculo-Descemet-membrane (TDM) window. As soon 
as the TDM window was created, percolation of the aque-
ous humor through the remaining peripheral Descemet’s 
membrane and/or SC was observed. A 150 μm canula (Visco 
Canalostomy Canula, 149.40, Grieshaber and Co. AG, 
Schaffhausen, Switzerland) was then inserted, through the 
two ostia, far inside SC and a high-molecular-weight sodium 
hyaluronate (Healon GV; Advanced Medical Optics Uppsala 
AB, Uppsala, Sweden) was repeatedly injected inside. The 
deep ﬂ  ap was excised with micro-scissors and the superﬁ  cial 
ﬂ  ap sutured with three separate 10-0 nylon sutures, creating 
an intrascleral space. Healon GV was then injected under 
the ﬂ  ap, into this intrascleral space. The conjunctiva was 
sutured using one or two separate 10-0 nylon sutures. The 
surgeon proceeded with the cataract extraction. Accordingly, 
a different-site, clear-cornea, temporal incision followed by 
a standard phacoemulsiﬁ  cation with a 3-piece intraocular 
lens (IOL) implantation was performed in all eyes. Patients 
were discharged one day after surgery. Topical antibiotic 
and anti-inﬂ  ammatory drops were prescribed postoperatively 
for 1 month.
Follow-up visits were scheduled on the ﬁ  rst day, ﬁ  rst 
week, first month and at 3-month intervals thereafter, 
throughout 36 months postoperatively. Best-corrected visual 
acuity measurement, IOP measurement, biomicroscopy, and 
fundoscopy were performed at each visit. On biomicros-
copy, attention was paid to the appearance of the surgical 
wound and to the presence or absence of a conjunctival bleb, 
anterior-chamber inﬂ  ammation, hyphema, and secondary Clinical Ophthalmology 2007:1(4) 499
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cataract development. During fundoscopy, the optic nerve 
was meticulously examined. Automated perimetry and optic-
disc stereo photography were performed every 6 months and 
12 months respectively.
The intraocular pressure was measured with a Goldmann 
applanation tonometer (without diurnal ﬂ  uctuation taken into 
account). Three measurements were recorded in each eye, and 
the mean value was used in the calculations. Best-corrected 
visual acuity was analyzed for study purposes by means of the 
logMAR score, proposed by Holladay (1997). The logMAR 
score derives by taking the logarithm (base 10) of the mini-
mum angle of resolution (MAR) or practically, logMAR = 
log (1/Decimal Acuity). A score of 0.0 in logMAR units is 
equivalent to a visual acuity of 20/20 on the Snellen acuity 
chart (1.0 being the Decimal equivalent), whereas a score 
of +1.0 is equivalent to 20/200 (0.1 being the Decimal equiva-
lent). Visual ﬁ  eld deterioration was graded according to the 
Hodapp-Anderson-Parrish severity scores (Hodapp et al 1993). 
If additional visits were needed, their results were included 
only if relevant for the main outcome measures. For patients 
referred only for surgery in the two participating institutions, 
detailed preoperative information was obtained from the 
referring ophthalmologist and they were brought in for further 
examination. Follow-up visits were always performed in either 
of the two participating institutions.
Outcome criteria and statistical analysis
Overall success was deﬁ  ned through the following criteria: no 
visual ﬁ  eld deterioration; no optic-neuropathy progression; 
postoperative IOP  20 mmHg and IOP reduction  30% 
compared to baseline values with or without medication. 
When medications were not required, success was deﬁ  ned as 
complete. Cases not fulﬁ  lling the aforementioned criteria and 
cases where a surgical revision or further goniopuncture was 
performed were deﬁ  ned as a failure. All statistical analyses 
were carried out using the SPSS 15.0 statistical software.
Results
Fifty eyes of 50 consecutive patients with medically uncon-
trolled OAG and age-related cataract underwent phaco-
viscocanalostomy. The surgical outcome, as well as the 
intraoperative and postoperative complication rates were 
documented and analyzed up to 36 months postoperatively. 
Mean follow-up (±SD) was 29.02 ± 7.09 months (range, 12 
to 36 months). One patient died 6 months after surgery due 
to a cardiovascular pathology, and was therefore excluded 
from the data analysis. Forty-nine, 39 and 16 of the remaining 
subjects reached the 12-, 24-, and 36-month follow-up visit 
respectively. The preoperative patients’ characteristics are 
synopsized in Table 1. Forty-three subjects (87.8%) were 
diagnosed with primary open-angle glaucoma (POAG), 
whereas the remaining six with pseudoexfoliation glaucoma 
(PEX). The mean age (±SD) at the time of operation was 
75.2 ± 6.4 years (range, 59–86 years). Preoperative dynamic 
gonioscopy revealed an open angle in all subjects. The mean 
ocular axial length (±SD) was 23.53 ± 1.41 mm. Seven 
subjects (14.3%) had a positive family history of glaucoma. 
The gender distribution was 28 male (57%) and 21 female. 
Forty-four patients (90%) were Caucasians, whereas ﬁ  ve 
cases belonged to the black-African race. Mean number of 
preoperative glaucoma medications (±SD) was 2.28 ± 0.91. 
The mean preoperative BCVA (±SD) in logMAR units was 
0.26 ± 0.11.
Mean IOP change after surgery is depicted in Figure 1. 
The mean preoperative IOP (±SD) under maximal tolerated 
medication of 23.51 ± 4.48 mmHg decreased to a mean post-
operative IOP of 7.84 ± 3.32 mmHg on the ﬁ  rst day, 11.30 ± 
4.12 mmHg at 1 week, 13.00 ± 3.36 mmHg at 6 months, 
13.60 ± 2.60 mmHg at 12 months, 14.30 ± 3.50 mmHg at 
24 months, and 14.30 ± 1.70 mmHg at 36 months. The mean 
baseline IOP (±SD) had signiﬁ  cantly decreased from 23.51 
± 4.48 mmHg to 14.06 ± 1.64 mmHg at the last follow-up 
visit for each patient (paired Student’s t-test, p  0.001). 
Similarly, the mean number of antiglaucoma medication 
(±SD) had dropped to 0.38 ± 0.86 in comparison with pre-
operative values (chi-square test, p  0.001). Our results 
indicate a 98% overall success rate at 6 months, 94% at 
Table 1 Patients’ characteristics before phacoviscocanalostomy
Diagnosis POAG  43  (88%)
 PEX  6  (12%)
Gender Male  28  (57%)
 Female  21  (43%)
Race Caucasian  44  (90%)
 Non-Caucasian  5  (10%)
Eye Right  22  (45%)
 Left  27  (55%)
Mean age ± SD (range)a  75.24 ± 6.23 years (59–86)
Mean axial length ± SD (range)  23.53 ± 1.41 mm (20.97–26.05)
Mean IOP ± SDb  23.51 ± 4.48 mmHg
Mean BCVA ± SDc  0.26 ± 0.11 logMAR
Mean number of antiglaucoma   2.28 ± 0.91
medications ± SD 
Previous Surgery  2 (4%)
Abbreviations: BCVA, best-corrected visual acuity; IOP, intraocular pressure; 
PEX, pseudoexfoliation glaucoma; POAG, primary open-angle glaucoma.
aAt the time of operation.
b Measured with a Goldmann applanation tonometer under maximal tolerated 
medication (without diurnal ﬂ  uctuation taken into account).
cVisual acuity in the logarithm of the minimum angle of resolution (logMAR).Clinical Ophthalmology 2007:1(4) 500
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12 months, 92% at 24 months, and 82% at 36 months. The 
success was complete in 88% of cases at 6 months, in 74% 
at 12 months, and in 67% at 24 months and at 36 months. 
The cumulative probability curves for overall and complete 
success are depicted in Figure 2. As it would be expected 
after phacoemulsiﬁ  cation with IOL implantation, the mean 
preoperative BCVA (±SD) in logMAR units of 0.26 ± 0.11
had signiﬁ  cantly improved to 0.07 ± 0.10 at the last follow-up 
visit for each patient (paired Student’s t-test, p  0.001). An 
improvement by 3 or more lines was achieved in 34 eyes 
(69%). Thirteen eyes (27%) gained up to 2 lines. However, 
one subject developed an idiopathic macular hole and lost 3 
lines of BCVA despite receiving a standard pars-plana vit-
rectomy with internal limiting membrane peeling. One other 
patient developed a recalcitrant, postoperative cystoid macu-
lar edema and lost 2 lines of BCVA. During the follow-up 
period, 3 eyes (6%) were subjected to neodymium-yttrium 
aluminum garnet (Nd:YAG) laser posterior capsulotomy due 
to secondary cataract development.
No serious complication was documented either during 
or after the operation (Table 2). In ﬁ  ve cases (10%) we 
documented a microhyphema, which disappeared spontane-
ously within 48 hours. Microperforation of the TDM was 
reported intraoperatively in three cases (6%), neither of 
which necessitated a peripheral iridectomy. One other case 
(2%) with a TDM perforation and iris prolapse was treated 
by peripheral iridectomy. Descemet’s membrane detachment 
was not reported in any case. At the ﬁ  nal follow-up visit for 
each patient, 7 subjects were deﬁ  ned as failure. In ﬁ  ve of 
these failures, IOP was higher than 21 mmHg despite addi-
tional antiglaucoma medication use, needing antiglaucoma 
surgery revision. Trabeculectomy with antimetabolite use 
was offered to one patient, whereas the remaining 4 cases 
received a same-site viscocanalostomy revision. In two 
subjects, glaucomatous optic-neuropathy progression was 
documented by fundus stereo photography and/or automated 
perimetry, despite sufﬁ  cient IOP control (IOP  20 mmHg 
with or without antiglaucoma medication).
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Figure 1 Mean intraocular pressure (IOP) change with standard deviation in patients following phacoviscocanalostomy.Clinical Ophthalmology 2007:1(4) 501
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Postoperatively, shallow ﬁ  ltration blebs were documented 
in 16 cases (33%). Nine (56%) of these blebs regressed 
spontaneously during the ﬁ  rst 12-month follow-up period. 
Neither persisting nor non-persisting blebs inﬂ  uenced success 
rates (Mantel-Cox, p  0.05 for each variable). None of 
the 49 subjects developed a bleb-related complication (ie, 
hypotony, hypotony-related maculopathy, blebitis or endo-
phthalmitis) during the follow-up period. Throughout the 
measurement period, there was no effect of gender, ethnicity 
or diagnosis (ie, POAG, PEX) on the overall success over 
time (Mantel-Cox, p  0.05 for each variable).
Discussion
Trabeculectomy is the standard procedure in managing medi-
cally uncontrolled OAG (Cairns 1968). In patients suffering 
from both OAG and cataract, phacotrabeculectomy appears 
to be a rational approach owing to a superior hypotensive 
effect compared to cataract surgery alone (Friedman et al 
2002). Interestingly, trabeculectomy alone appears to be 
more effective in lowering IOP than phacotrabeculectomy 
(Bellucci et al 1997; Lochhead et al 2003). Alone or in com-
bination with phacoemulsiﬁ  cation, trabeculectomy is asso-
ciated with potentially serious postoperative complications 
(Bellucci et al 1997; Sihota et al 1998; DeBry et al 2002; 
Edmunds et al 2002). Non-penetrating glaucoma surgery, in 
the form of viscocanalostomy, has gained increasing interest 
because it can both reduce IOP and signiﬁ  cantly minimize 
the surgical complications related to conventional ﬁ  ltration 
Figure 2 Cumulative probability of overall (solid line) and complete (dotted line) success in patients following phacoviscocanalostomy. Overall success was deﬁ  ned through 
the following criteria: no visual ﬁ  eld deterioration; no optic-neuropathy progression; postoperative IOP ≤ 20 mmHg and IOP reduction ≥ 30% compared to baseline values 
with or without medication. When medications were not required, success was deﬁ  ned as complete.
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Table 2  Intraoperative and postoperative complications
None 40  (82%)
Microhyphemaa 5  (10%)
TDM Microperforation  3 (6%)
TDM perforation with peripheral iridectomy  1 (2%)
Abbreviation: TDM, trabeculo-Descemet’s-membrane.
aSpontaneously regressed (within 48 hours).Clinical Ophthalmology 2007:1(4) 502
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procedures (Stegmann et al 1999; Drusedau et al 2000; 
Sunaric-Megevand and Leuenberger 2001; Carassa et al 
2002; Stangos et al 2005). Similarly, phacoviscocanalostomy 
has shown to efﬁ  ciently and safely reduce IOP in cases with 
OAG and clinically signiﬁ  cant cataract (Gimbel et al 1999; 
Tanito et al 2002; Wishart et al 2002; Uretmen et al 2003; 
Park et al 2004, 2006; Wishart and Dagres 2006; Kobayashi H 
and Kobayashi K 2007).
In accordance with previously published phacovisco-
canalostomy studies (Gimbel et al 1999; Tanito et al 2002; 
Wishart et al 2002; Uretmen et al 2003; Park et al 2004, 2006; 
Wishart and Dagres 2006; Kobayashi H and Kobayashi K 
2007), in the current study, the mean baseline IOP (±SD) had 
signiﬁ  cantly dropped from 23.51 ± 4.48 mmHg to 14.06 ± 
1.64 mmHg at the last follow-up visit for each patient (paired 
Student’s t-test, p  0.001). Similarly, the mean number of 
antiglaucoma medication (±SD) had dropped to 0.38 ± 0.86 in 
comparison with preoperative values (paired Student’s t-test, 
p  0.001). The overall success of phacoviscocanalostomy 
at the last visit for each patient was 86% (42 from 49 eyes) 
and the complete success was 67% (33 from 49 eyes). Seven 
eyes (14%) were classiﬁ  ed as a failure. Two of these failures 
have shown progression of glaucomatous neuropathy irre-
spective of good IOP control with or without antiglaucoma 
medication. Four of the 5 cases that experienced unsatisfac-
tory postoperative IOP values received a viscocanalostomy 
revision through the same surgical site with excellent results 
(IOP  20 mmHg with concomitant reduction  30% 
compared to baseline values). Previous favorable results of 
surgical revision (same site approach) for viscocanalostomy 
failures in POAG make us advocates of that approach (Suna-
ric-Megevand G. unpublished data, 2004).
Viscocanalostomy avoids intraoperative and postopera-
tive complications related to penetrating ﬁ  ltration procedures 
(Bellucci et al 1997; Sihota et al 1998; DeBry et al 2002; 
Edmunds et al 2002). Similarly to previous viscocanalostomy 
and phacoviscocanalostomy studies (Gimbel et al 1999; 
Stegmann et al 1999; Drusedau et al 2000; Sunaric-Megevand 
and Leuenberger 2001; Carassa et al 2002; Tanito et al 2002; 
Wishart et al 2002; Uretmen et al 2003; Miserocchi et al 
2004; Park et al 2004, 2006; Stangos et al 2005; Wishart and 
Dagres 2006), in the present study, no serious complications 
were documented either during or after the operation. In ﬁ  ve 
cases (10%), however, we documented a spontaneously reab-
sorbed microhyphema, which was attributed to blood reﬂ  ux 
through the collector channels and the SC. Microperforation 
of the TDM was reported intraoperatively in three cases 
(6%), neither of which necessitated a peripheral iridectomy. 
One other case (2%) with a TDM perforation and iris prolapse 
was treated by peripheral iridectomy. During the follow-up 
period, none of the 49 subjects developed a bleb-related 
complication, such as hypotony, hypotony-related macu-
lopathy, blebitis or endophthalmitis.
The exact mode of action of this non-penetrating 
antiglaucoma surgical modality is not completely understood. 
However, viscocanalostomy has been proven to create a 
direct communication between SC and the juxtacanalicular 
space (Smit and Johnstone 2002; Takahashi et al 2004; 
Tamm et al 2004), overcoming the major element of aque-
ous outﬂ  ow resistance, the juxtacanalicular tissue (Seiler 
and Wollensak 1985; Ethier et al 1986). Furthermore, the 
viscoelastic material (high-molecular-weight sodium hyal-
uronate) injected into SC and the intrascleral lake, could play 
an important role in healing modulation (Forrester and Balazs 
1977; Forrester and Balazs 1980; Forrester and Wilkinson 
1981), decreasing postoperative ﬁ  brosis on the surgical 
wound, a well-known risk factor for ﬁ  ltration-surgery failure 
(Skuta and Parrish 1987). Although viscocanalostomy was 
not originally designed to rely on external ﬁ  ltration as the 
principal mode of action, the sub-conjunctival outﬂ  ow path-
way cannot be excluded. Previous ultrabiomicroscopy studies 
have sporadically shown shallow ﬁ  ltering blebs in POAG 
cases after successful, uneventful viscocanalostomy surgery 
(Sunaric-Megevand G. unpublished data, 2002). Similarly, in 
the current study, shallow ﬁ  ltration blebs were documented 
after surgery in 16 cases (33%). Nine (56%) of these blebs 
regressed spontaneously during the ﬁ  rst 12-month follow-
up period. However, neither persisting nor non-persisting 
blebs inﬂ  uenced success rates (Mantel-Cox, p  0.05 for 
each variable).
The unfavorable inﬂ  uence of previous ﬁ  ltering surgery on 
the outcome of a subsequent ﬁ  ltration surgery has already been 
shown (Schwartz and Anderson 1974). In our series, only two 
eyes (4%) have been previously operated for glaucoma (ie, 
trabeculectomy). Both cases were classiﬁ  ed as a failure during 
the follow-up period, representing almost a third of all failures. 
Accordingly, we believe the fact that viscocanalostomy was 
the primary surgical modality offered to the majority of our 
cases (96%), positively inﬂ  uenced the surgical outcome of this 
study. Viscocanalostomy is a challenging technique to master, 
partly due to its long learning curve (Sunaric-Megevand G. 
ARVO Meeting, 2003, Abstract, and Stangos A.N. 6th Inter-
national Glaucoma Symposium, 2007, Abstract). Thus, the 
surgical outcome may have been positively inﬂ  uenced also 
by the fact that the performing physician was an experienced 
phacoemulsiﬁ  cation and viscocanalostomy surgeon.Clinical Ophthalmology 2007:1(4) 503
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In contrast to phacotrabeculectomy, which appears to 
be less effective than trabeculectomy alone (Bellucci et al 
1997; Lochhead et al 2003), phacoviscocanalostomy was 
reported to produce a similar hypotensive effect compared 
to viscocanalostomy alone (Wishart et al 2002). If we also 
take into consideration the cost effectiveness of combined 
versus two-stage procedures, phacoviscocanalostomy 
appears to be a rational therapeutic approach for the treat-
ment of uncontrolled OAG with concomitant age-related 
cataract. In accordance with previously published phaco-
viscocanalostomy studies (Gimbel et al 1999; Tanito et al 
2002; Wishart et al 2002; Uretmen et al 2003; Park et al 
2004, 2006; Wishart and Dagres 2006), the current study 
offers very good results for the treatment of OAG with 
concomitant age-related cataract, with relatively few and 
mild complications. Furthermore, taking into account the 
potentially serious complications of phacotrabeculectomy 
(Bellucci et al 1997; Sihota et al 1998; DeBry et al 2002; 
Edmunds et al 2002), the need for safer and still effective 
alternative surgical procedures is mandatory. Phacovisco-
canalostomy can be considered an efﬁ  cient and safe alter-
native surgical modality for medically uncontrolled OAG 
with concomitant age-related cataract. Nevertheless, larger, 
randomized, comparative studies would provide stronger 
evidence of the efﬁ  ciency and safety of phacoviscocanalos-
tomy for such cases.
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